Inpatient healthcare utilisation in patients with alcoholic liver disease: what are the costs and outcomes?

<br/><strong>Background: </strong>Alcoholic liver disease (ALD) carries a significant cost burden and often leads to inpatient care. It is unclear whether inpatient care for ALD is any more costly than admission for other reasons.<br/><strong>Aims: </strong>To com...

Full description

Bibliographic Details
Main Authors: Williamson, KD, Gill, MG, Andrews, JM, Harley, HAJ
Format: Journal article
Language:English
Published: Wiley 2016
_version_ 1826261283099377664
author Williamson, KD
Gill, MG
Andrews, JM
Harley, HAJ
author_facet Williamson, KD
Gill, MG
Andrews, JM
Harley, HAJ
author_sort Williamson, KD
collection OXFORD
description <br/><strong>Background: </strong>Alcoholic liver disease (ALD) carries a significant cost burden and often leads to inpatient care. It is unclear whether inpatient care for ALD is any more costly than admission for other reasons.<br/><strong>Aims: </strong>To compare the costs and outcomes of inpatient care for ALD to two groups: a control group of matched cases admitted in the same time frame and people admitted for other chronic liver diseases (CLD).<br/><strong>Methods: </strong>All admissions for ALD and other CLD in a 3‐month period were retrospectively identified. Five randomly identified gender‐ and age‐matched contemporaneously admitted controls were allocated. Length of stay (LoS), mortality, inpatient costs, blood product utilisation and discharge destination were compared.<br/><strong>Results: </strong>Of the 71 admissions due to CLD, ALD was the most frequent cause (53/71, 75%). ALD admissions cost more (median $10 100 vs $5294; P = 0.0012) and had greater LoS (median LoS 7.2 days (interquartile range (IQR) 0.2–40.7)) than controls (2.6 days (IQR 1.1–6.8); P = 0.0001). A larger proportion of the ALD cohort required blood transfusion and had a higher mortality than controls (24.5 vs 6.4%, P = 0.002 and 13.2 vs 0.2%; P &lt; 0.0001 respectively). Self‐discharge was more common in the ALD group (13.2 vs 1.1%, P &lt; 0.0001).<br/><strong>Conclusions: </strong>ALD inpatient hospital admissions have greater median total cost, longer LoS, greater blood product utilisation, higher mortality and greater rate of discharge against medical advice than age‐ and gender‐matched controls. These data emphasise the large inpatient care burden, high mortality and suboptimal engagement in those with ALD, which justifies the more active provision of services for ALD.
first_indexed 2024-03-06T19:19:00Z
format Journal article
id oxford-uuid:19673708-9608-49dc-a17a-f24c80ab7eab
institution University of Oxford
language English
last_indexed 2024-03-06T19:19:00Z
publishDate 2016
publisher Wiley
record_format dspace
spelling oxford-uuid:19673708-9608-49dc-a17a-f24c80ab7eab2022-03-26T10:48:53ZInpatient healthcare utilisation in patients with alcoholic liver disease: what are the costs and outcomes?Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:19673708-9608-49dc-a17a-f24c80ab7eabEnglishSymplectic Elements at OxfordWiley2016Williamson, KDGill, MGAndrews, JMHarley, HAJ<br/><strong>Background: </strong>Alcoholic liver disease (ALD) carries a significant cost burden and often leads to inpatient care. It is unclear whether inpatient care for ALD is any more costly than admission for other reasons.<br/><strong>Aims: </strong>To compare the costs and outcomes of inpatient care for ALD to two groups: a control group of matched cases admitted in the same time frame and people admitted for other chronic liver diseases (CLD).<br/><strong>Methods: </strong>All admissions for ALD and other CLD in a 3‐month period were retrospectively identified. Five randomly identified gender‐ and age‐matched contemporaneously admitted controls were allocated. Length of stay (LoS), mortality, inpatient costs, blood product utilisation and discharge destination were compared.<br/><strong>Results: </strong>Of the 71 admissions due to CLD, ALD was the most frequent cause (53/71, 75%). ALD admissions cost more (median $10 100 vs $5294; P = 0.0012) and had greater LoS (median LoS 7.2 days (interquartile range (IQR) 0.2–40.7)) than controls (2.6 days (IQR 1.1–6.8); P = 0.0001). A larger proportion of the ALD cohort required blood transfusion and had a higher mortality than controls (24.5 vs 6.4%, P = 0.002 and 13.2 vs 0.2%; P &lt; 0.0001 respectively). Self‐discharge was more common in the ALD group (13.2 vs 1.1%, P &lt; 0.0001).<br/><strong>Conclusions: </strong>ALD inpatient hospital admissions have greater median total cost, longer LoS, greater blood product utilisation, higher mortality and greater rate of discharge against medical advice than age‐ and gender‐matched controls. These data emphasise the large inpatient care burden, high mortality and suboptimal engagement in those with ALD, which justifies the more active provision of services for ALD.
spellingShingle Williamson, KD
Gill, MG
Andrews, JM
Harley, HAJ
Inpatient healthcare utilisation in patients with alcoholic liver disease: what are the costs and outcomes?
title Inpatient healthcare utilisation in patients with alcoholic liver disease: what are the costs and outcomes?
title_full Inpatient healthcare utilisation in patients with alcoholic liver disease: what are the costs and outcomes?
title_fullStr Inpatient healthcare utilisation in patients with alcoholic liver disease: what are the costs and outcomes?
title_full_unstemmed Inpatient healthcare utilisation in patients with alcoholic liver disease: what are the costs and outcomes?
title_short Inpatient healthcare utilisation in patients with alcoholic liver disease: what are the costs and outcomes?
title_sort inpatient healthcare utilisation in patients with alcoholic liver disease what are the costs and outcomes
work_keys_str_mv AT williamsonkd inpatienthealthcareutilisationinpatientswithalcoholicliverdiseasewhatarethecostsandoutcomes
AT gillmg inpatienthealthcareutilisationinpatientswithalcoholicliverdiseasewhatarethecostsandoutcomes
AT andrewsjm inpatienthealthcareutilisationinpatientswithalcoholicliverdiseasewhatarethecostsandoutcomes
AT harleyhaj inpatienthealthcareutilisationinpatientswithalcoholicliverdiseasewhatarethecostsandoutcomes